(Q24241711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

1 reference

title

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Miny Samuel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Edwin Chan Shih-Yen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

David Machin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Khee-Chee Soo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

21 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

CD001199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19160192%20AND%20SRC:MED&resulttype=core&format=json

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

20 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD001199.PUB2

A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD001199.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD001199.PUB2

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

21 January 2018

1 reference

12 December 2020

Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

12 December 2020

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

1 reference

12 December 2020

Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma

1 reference

12 December 2020

Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong Kong

1 reference

12 December 2020

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

12 December 2020

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial

1 reference

12 December 2020

Treatment of hepatocellular carcinoma

1 reference

12 December 2020

Primary hepatocellular carcinoma in the Asian Pacific region

1 reference

12 December 2020

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

1 reference

12 December 2020

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

12 December 2020

Hepatocellular carcinoma: recent trends in the United States

1 reference

12 December 2020

Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma

1 reference

12 December 2020

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

12 December 2020

Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study

1 reference

12 December 2020

Multidisciplinary management of hepatocellular carcinoma

1 reference

12 December 2020

Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma

1 reference

12 December 2020

Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy

1 reference

12 December 2020

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

12 December 2020

Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study

1 reference

12 December 2020

Hepatocellular carcinoma--a case series of 104 patients

1 reference

12 December 2020

Prognosis of primary hepatocellular carcinoma

1 reference

12 December 2020

Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma.

1 reference

12 December 2020

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

12 December 2020

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

12 December 2020

Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal

1 reference

12 December 2020

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

12 December 2020

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

12 December 2020

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

12 December 2020

The surgical management of primary carcinoma of the liver

1 reference

12 December 2020